CDI = Clostridium difficile infection, UTI = Urinary tract infection, n = total sample size, N = weighted average annual population estimate, CI = confidence interval ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

old mumbai chart PNAS: New drug therapy for Clostridium difficile infection is expected to be developed The 2019 chemical drug quality failure ranking list was released, with Nanjing Baijingyu ...

PF-06425090 is under clinical development by Pfizer and currently in Phase III for Clostridioides difficile Infections (Clostridium difficile Associated Disease). According to GlobalData, Phase III ...

Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

Positive results of Phase 2a clinical trial of innovative therapy for Clostridium difficile infection The development history of Good Laboratory Practice (GLP) The Lancet's large-scale ...

Windows app download Hydrogel helps CAR-T therapy to treat eye cancer Consumables are reduced by up to 80% for Medtronic, Boco, Fresenius... All pa ...